血液検査:医療機器パイプライン分析2019

調査会社GlobalData社が発行したリサーチレポート(データ管理コード:GDATA9120291)
◆英語タイトル:Hematology Tests - Medical Devices Pipeline Assessment, 2019
◆発行会社/調査会社:GlobalData
◆商品コード:GDATA9120291
◆発行日:2019年11月
◆調査対象地域:グローバル
◆産業分野:医療機器
◆ページ数:136
◆レポート言語:英語
◆レポート形式:PDF
◆納品方式:Eメール(受注後24時間以内)
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,000 ⇒換算¥456,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD8,000 ⇒換算¥912,000見積依頼/購入/質問フォーム
Enterprisewide Price(複数事業所内共有可)USD12,000 ⇒換算¥1,368,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[血液検査:医療機器パイプライン分析2019]についてメールでお問い合わせはこちら
*** レポート概要(サマリー)***

Hematology Tests – Medical Devices Pipeline Assessment, 2019
Summary

GlobalData’s Medical Devices sector report, “Hematology Tests – Medical Devices Pipeline Assessment, 2019″ provides an overview of Hematology Tests currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Hematology Tests pipeline products.
This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData’s team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Hematology Tests under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Hematology Tests and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to –
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Hematology Tests under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date

*** レポート目次(コンテンツ)***

Table of Contents
1.1 List of Tables 5
1.2 List of Figures 6
2 Introduction 7
2.1 Hematology Tests Overview 7
3 Products under Development 9
3.1 Hematology Tests – Pipeline Products by Stage of Development 9
3.2 Hematology Tests – Pipeline Products by Segment 10
3.3 Hematology Tests – Pipeline Products by Territory 11
3.4 Hematology Tests – Pipeline Products by Regulatory Path 12
3.5 Hematology Tests – Pipeline Products by Estimated Approval Date 13
4 Hematology Tests – Pipeline Products under Development by Companies 14
4.1 Hematology Tests Companies – Pipeline Products by Stage of Development 14
4.2 Hematology Tests – Pipeline Products by Stage of Development 15
5 Hematology Tests Companies and Product Overview 16
5.1 Aptitude Medical Systems Inc Company Overview 16
5.1.1 Aptitude Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 16
5.2 BioMedomics Inc Company Overview 17
5.2.1 BioMedomics Inc Pipeline Products & Ongoing Clinical Trials Overview 17
5.3 Biosurfit, SA Company Overview 21
5.3.1 Biosurfit, SA Pipeline Products & Ongoing Clinical Trials Overview 21
5.4 Correlia Biosystems, Inc. Company Overview 23
5.4.1 Correlia Biosystems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 23
5.5 DxDiscovery, Inc. Company Overview 24
5.5.1 DxDiscovery, Inc. Pipeline Products & Ongoing Clinical Trials Overview 24
5.6 Dynasil Corporation of America Company Overview 25
5.6.1 Dynasil Corporation of America Pipeline Products & Ongoing Clinical Trials Overview 25
5.7 ET Healthcare Inc Company Overview 26
5.7.1 ET Healthcare Inc Pipeline Products & Ongoing Clinical Trials Overview 26
5.8 genedrive plc Company Overview 27
5.8.1 genedrive plc Pipeline Products & Ongoing Clinical Trials Overview 27
5.9 Group K Diagnostics Company Overview 28
5.9.1 Group K Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 28
5.10 hemCheck Sweden AB Company Overview 29
5.10.1 hemCheck Sweden AB Pipeline Products & Ongoing Clinical Trials Overview 29
5.11 Ohio State University Company Overview 30
5.11.1 Ohio State University Pipeline Products & Ongoing Clinical Trials Overview 30
5.12 PortaScience Inc Company Overview 31
5.12.1 PortaScience Inc Pipeline Products & Ongoing Clinical Trials Overview 31
5.13 Retham Technologies LLC Company Overview 32
5.13.1 Retham Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 32
5.14 Sanguina LLC Company Overview 33
5.14.1 Sanguina LLC Pipeline Products & Ongoing Clinical Trials Overview 33
5.15 Siemens Healthineers AG Company Overview 34
5.15.1 Siemens Healthineers AG Pipeline Products & Ongoing Clinical Trials Overview 34
5.16 T2 Biosystems Inc Company Overview 40
5.16.1 T2 Biosystems Inc Pipeline Products & Ongoing Clinical Trials Overview 40
5.17 University of Glasgow Company Overview 42
5.17.1 University of Glasgow Pipeline Products & Ongoing Clinical Trials Overview 42
5.18 University of Melbourne Company Overview 43
5.18.1 University of Melbourne Pipeline Products & Ongoing Clinical Trials Overview 43
6 Hematology Tests- Recent Developments 44
6.1 Oct 16, 2019: Orgenesis announces Co-Development Agreement with Accellix 44
6.2 Sep 30, 2019: Halo Labs provides Oregon business update company projects record September sales orders in Oregon 44
6.3 Sep 16, 2019: Sysmex America joins Clinical Lab 2.0 Movement to support collaboration around value-based healthcare 45
6.4 Sep 11, 2019: Bio-Rad files new lawsuit against 10X Genomics for Patent Infringement 46
6.5 Sep 10, 2019: EKF Diagnostics Holdings: Half-year Report 46
6.6 Aug 29, 2019: Siemens Healthineers announces new Canadian leadership 47
6.7 Aug 26, 2019: Halo Labs awarded two permanent licenses at second California facility 48
6.8 Aug 14, 2019: Biohit Group half year financial report 2019 48
6.9 Aug 14, 2019: Accellix announces the appointment of Charles Piazza to its board of directors 56
6.10 Aug 12, 2019: Halo Labs reports Q2 2019 financial results 57
6.11 Aug 08, 2019: Quidel reports second quarter 2019 Financial Results 58
6.12 Aug 01, 2019: Bio-Rad reports second-quarter 2019 financial results 60
6.13 Jul 29, 2019: Siemens Healthineers continues to drive growth forward 61
6.14 Jul 29, 2019: Changes in the Managing Board of Siemens Healthineers 63
6.15 Jul 24, 2019: Delaware District Court grants Bio-Rad’s Motion for Permanent Injunction against 10X Genomics 63
6.16 Jul 16, 2019: Universal Biosensors: Commentary on Q2 2019 appendix 4C cash flow summary 64
6.17 Jul 15, 2019: Consort Medical: Incident at the Aesica Cramlington API facility 64
6.18 Jul 15, 2019: EKF Diagnostics Holdings: Trading update 65
6.19 Jul 01, 2019: Disgraced Theranos founder Elizabeth Holmes to stand trial in 2020 65
6.20 Jun 26, 2019: Universal Biosensors: Business Update 66
6.21 Jun 18, 2019: Halo Labs intends to appoint Ms. Louisa Mojela as Chairman of the Board upon closing of bophelo bioscience acquisition 66
6.22 Jun 13, 2019: Consort Medical reports a solid performance and announces new contract awards 67
6.23 Jun 01, 2019: Greg Milosevich appointed President of Beckman Coulter Life Sciences 78
6.24 May 20, 2019: Akers Biosciences reports Q1 2019 earnings 78
6.25 May 08, 2019: Bio-Rad reports first quarter 2019 financial results 78
6.26 May 08, 2019: Quidel reports first quarter 2019 financial results 81
6.27 May 02, 2019: Siemens Healthineers posts strong revenue and profit growth in the second quarter 82
6.28 May 01, 2019: Halo Labs moves west 83
6.29 Apr 23, 2019: Universal Biosensors: Commentary on Q1 2019 appendix 4C cash flow summary 83
6.30 Apr 22, 2019: Bio-Rad Laboratories names Andrew Last as executive vice president and chief operating officer 84
6.31 Apr 02, 2019: Bio-Rad Laboratories appoints Ilan Daskal as executive vice president and chief financial officer 84
6.32 Apr 01, 2019: Akers Biosciences reports fiscal year 2018 earnings 85
6.33 Mar 13, 2019: EKF Diagnostics Holdings: Final results 85
6.34 Mar 08, 2019: Universal Biosensors announces resignation of CEO Rick Legleiter 91
6.35 Feb 28, 2019: Bio-Rad Laboratories announces fourth-quarter and full-year 2018 financial results 91
6.36 Feb 20, 2019: Biohit group financial statement release 2018 93
6.37 Feb 13, 2019: Quidel Reports Fourth Quarter and Full Year 2018 Financial Results 100
6.38 Feb 11, 2019: Siemens Healthineers to invest EUR 350 million in new Campus Forchheim 102
6.39 Feb 05, 2019: Akers Biosciences: Further Re. Directorate change 103
6.40 Jan 29, 2019: Universal Biosensors: Commentary on FY 2018 103
6.41 Jan 25, 2019: Introducing DiaSys’ new CEO Dr. Jan Gorka 104
6.42 Jan 07, 2019: Quidel Announces Preliminary Revenue for Fourth Quarter 2018 105
6.43 Jan 03, 2019: Bio-Rad finance chief to retire 105
6.44 Jan 03, 2019: Christine Tsingos announces plans to retire as CFO of Bio-Rad Laboratories 105
7 Appendix 133
7.1 Methodology 133
7.2 About GlobalData 136
7.3 Contact Us 136
7.4 Disclaimer 136

List of Tables
Table 1: Hematology Tests - Pipeline Products by Stage of Development 9
Table 2: Hematology Tests - Pipeline Products by Segment 10
Table 3: Hematology Tests - Pipeline Products by Territory 11
Table 4: Hematology Tests - Pipeline Products by Regulatory Path 12
Table 5: Hematology Tests - Pipeline Products by Estimated Approval Date 13
Table 6: Hematology Tests Companies - Pipeline Products by Stage of Development 14
Table 7: Hematology Tests - Pipeline Products by Stage of Development 15
Table 8: Aptitude Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 16
Table 11: BioMedomics Inc Pipeline Products & Ongoing Clinical Trials Overview 17
Table 22: Biosurfit, SA Pipeline Products & Ongoing Clinical Trials Overview 21
Table 27: Correlia Biosystems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 23
Table 30: DxDiscovery, Inc. Pipeline Products & Ongoing Clinical Trials Overview 24
Table 33: Dynasil Corporation of America Pipeline Products & Ongoing Clinical Trials Overview 25
Table 36: ET Healthcare Inc Pipeline Products & Ongoing Clinical Trials Overview 26
Table 39: genedrive plc Pipeline Products & Ongoing Clinical Trials Overview 27
Table 42: Group K Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 28
Table 45: hemCheck Sweden AB Pipeline Products & Ongoing Clinical Trials Overview 29
Table 48: Ohio State University Pipeline Products & Ongoing Clinical Trials Overview 30
Table 51: PortaScience Inc Pipeline Products & Ongoing Clinical Trials Overview 31
Table 54: Retham Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 32
Table 57: Sanguina LLC Pipeline Products & Ongoing Clinical Trials Overview 33
Table 60: Siemens Healthineers AG Pipeline Products & Ongoing Clinical Trials Overview 34
Table 75: T2 Biosystems Inc Pipeline Products & Ongoing Clinical Trials Overview 40
Table 80: University of Glasgow Pipeline Products & Ongoing Clinical Trials Overview 42
Table 83: University of Melbourne Pipeline Products & Ongoing Clinical Trials Overview 43
Table 86: Glossary 135

List of Figures
Figure 1: Hematology Tests - Pipeline Products by Stage of Development 9
Figure 2: Hematology Tests - Pipeline Products by Segment 10
Figure 3: Hematology Tests - Pipeline Products by Territory 11
Figure 4: Hematology Tests - Pipeline Products by Regulatory Path 12
Figure 5: Hematology Tests - Pipeline Products by Estimated Approval Date 13

*** 掲載企業 ***

Aptitude Medical Systems Inc
BioMedomics Inc
Biosurfit, SA
Correlia Biosystems, Inc.
DxDiscovery, Inc.
Dynasil Corporation of America
ET Healthcare Inc
genedrive plc
Group K Diagnostics
hemCheck Sweden AB
Ohio State University
PortaScience Inc
Retham Technologies LLC
Sanguina LLC
Siemens Healthineers AG
T2 Biosystems Inc
University of Glasgow
University of Melbourne

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/


※おすすめ調査資料
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(GDATA9120291 )"血液検査:医療機器パイプライン分析2019" (英文:Hematology Tests - Medical Devices Pipeline Assessment, 2019)はGlobalData社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。